Hanall Biopharma Co., Ltd. (KRX:009420)

Hanall Biopharma Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 4, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	2,594,851	1,959,952	2,245,705	902,290	1,077,892	1,919,220
Market Cap Growth	13.84%	-12.72%	148.89%	-16.29%	-43.84%	3.31%
Enterprise Value	2,584,269	1,934,197	2,185,410	836,710	991,822	1,831,333
Last Close Price	51100.00	38650.00	44300.00	17800.00	21050.00	37500.00
PE Ratio	1123.15	-	640.06	3588.03	121.16	97.10
Forward PE	358.90	117.15	261.09	112.30	65.12	88.99
PS Ratio	16.84	14.11	16.65	8.20	10.61	21.66
PB Ratio	16.46	11.64	12.06	5.36	6.59	10.59
P/TBV Ratio	27.00	11.96	12.18	5.43	6.68	10.74
P/FCF Ratio	208.07	253.93	82.47	40.22	-	-
P/OCF Ratio	187.11	209.40	75.76	35.71	1283.40	2065.25
PEG Ratio	-	19.09	19.09	19.09	19.09	30.69
EV/Sales Ratio	16.78	13.92	16.20	7.61	9.76	20.67
EV/EBITDA Ratio	-	577.20	437.93	183.55	77.34	207.41
EV/EBIT Ratio	-	8392.22	1253.51	555.66	98.21	308.56
EV/FCF Ratio	207.22	250.60	80.26	37.30	-	-
Debt / Equity Ratio	0.01	0.01	0.01	0.01	0.01	0.00
Debt / EBITDA Ratio	0.18	0.43	0.26	0.29	0.10	0.06
Debt / FCF Ratio	0.11	0.19	0.05	0.06	-	-
Asset Turnover	0.74	0.61	0.60	0.53	0.49	0.43
Inventory Turnover	1.95	1.88	2.08	2.11	2.05	2.26
Quick Ratio	0.82	1.29	2.10	2.97	4.35	4.61
Current Ratio	2.01	2.46	3.02	3.92	5.37	5.61
Return on Equity (ROE)	1.40%	-1.02%	1.98%	0.15%	5.16%	12.29%
Return on Assets (ROA)	1.16%	0.06%	0.48%	0.46%	3.02%	1.80%
Return on Capital (ROIC)	1.45%	0.08%	0.61%	0.56%	3.64%	2.30%
Return on Capital Employed (ROCE)	2.30%	0.10%	0.90%	0.80%	5.70%	3.00%
Earnings Yield	0.09%	-0.09%	0.16%	0.03%	0.83%	1.03%
FCF Yield	0.48%	0.39%	1.21%	2.49%	-0.35%	-0.08%
Buyback Yield / Dilution	1.06%	-0.04%	0.24%	0.76%	-0.05%	-0.00%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.